Alendronic acid or alendronate sodium
- Level
- Commodity
- Parent
- 51182400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182406This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C4H13NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X1J18R4W8P, chemically known as 4-amino-1-hydroxybutylidene-1,1-bis(phosphonic acid) but generally known as alendronate, which bears US NIH Compound Identifier 2088. Alendronate comes in forms hydrate, sodium, and trihydrate. European Medicines Agency schedules Alendronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05307MIG. The term ALENDRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules alendronate in its Anatomical Therapeutic Chemical (ATC) Classification. Alendronic acid or alendronate sodium bears US NLM identifiers UMLS ID C0700482 and NCI Concept Code C973. SMILES: C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN.
Same parent
Under 51182400 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.